Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I safety study of intraoperative hyperthermic cisplatin chemotherapy with pleural dissemination resection in children and AYA patients
jRCTs031230736Phase 1Recruiting
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of cisplatin in cancer. Primary endpoints: Dose-limiting toxicity and Intraoperative and postoperative adverse events and complications. Started Mar 2024; status: recruiting.
02
Drugs
cisplatin
03
Conditions
cancer
Beyond the preview
Go deeper on jRCTs031230736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031230736.